Retour
Fourchette du Jour
199,67 €
214,29 €
Fourchette 52 Semaines
93,58 €
227,92 €
Volume
255 600
Moyenne 50J / 200J
197,85 €
/
172,55 €
Clôture Précédente
204,81 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 32,1 | 0,4 |
| P/B | 3,9 | 2,9 |
| ROE % | 13,5 | 3,8 |
| Net Margin % | 46,4 | 3,9 |
| Rev Growth 5Y % | 2,6 | 10,0 |
| D/E | 0,4 | 0,2 |
Objectif de Cours des Analystes
Hold
248,00 €
+23.8%
Low: 230,00 €
High: 275,00 €
P/E Prévisionnel
23,2
BPA Prévisionnel
8,63 €
Croissance BPA (est.)
+0,0%
CA Est.
270 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
14,51 €
13,65 € – 15,62 €
|
510 M | 1 |
| FY2029 |
11,25 €
10,58 € – 12,11 €
|
420 M | 1 |
| FY2028 |
10,31 €
8,99 € – 11,62 €
|
370 M | 2 |
Points Clés
Revenue grew 2,64% annually over 5 years — modest growth
ROE of 13,47% — decent returns on equity
Net margin of 46,42% shows strong profitability
Debt/Equity of 0,44 — conservative balance sheet
Generating 48,91M in free cash flow
P/E of 32,10 — premium valuation
Croissance
Revenue Growth (5Y)
2,64%
Revenue (1Y)60,40%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
13,47%
ROIC2,41%
Net Margin46,42%
Op. Margin17,61%
Sécurité
Debt / Equity
0,44
Current Ratio22,23
Interest Coverage0,00
Valorisation
P/E Ratio
32,10
P/B Ratio3,93
EV/EBITDA90,51
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 60,40% | Revenue Growth (3Y) | 42,88% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | 54,48% |
| Revenue Growth (5Y) | 2,64% | Earnings Growth (5Y) | 21,48% |
| Profitability | |||
| Revenue (TTM) | 268,09M | Net Income (TTM) | 124,45M |
| ROE | 13,47% | ROA | 7,97% |
| Gross Margin | 97,54% | Operating Margin | 17,61% |
| Net Margin | 46,42% | Free Cash Flow (TTM) | 48,91M |
| ROIC | 2,41% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,44 | Current Ratio | 22,23 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 32,10 | P/B Ratio | 3,93 |
| P/S Ratio | 14,90 | PEG Ratio | -0,01 |
| EV/EBITDA | 90,51 | Dividend Yield | 0,00% |
| Market Cap | 4,00B | Enterprise Value | 4,27B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 268,09M | 167,13M | 131,31M | 196,25M | 241,54M |
| Net Income | 124,45M | -4,03M | 52,15M | -33,36M | 57,14M |
| EPS (Diluted) | 6,13 | -0,22 | 2,94 | -1,98 | 3,34 |
| Gross Profit | 261,50M | 156,06M | 96,27M | 143,42M | 179,37M |
| Operating Income | 47,20M | -22,61M | 11,94M | 3,04M | 103,85M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,56B | 941,77M | 787,22M | 762,67M | 1,30B |
| Total Liabilities | 543,43M | 111,34M | 86,30M | 165,18M | 476,43M |
| Shareholders' Equity | 1,02B | 830,44M | 700,91M | 597,49M | 821,16M |
| Total Debt | 451,49M | 7,11M | 6,17M | 87,75M | 324,39M |
| Cash & Equivalents | 174,93M | 72,31M | 22,95M | 45,01M | 19,52M |
| Current Assets | 832,27M | 331,56M | 237,43M | 263,60M | 464,75M |
| Current Liabilities | 37,45M | 37,11M | 16,78M | 98,81M | 41,67M |